Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Targeting molecular mechanisms underlying treatment efficacy and resistance in osteosarcoma: a review of current and future strategies
I Lilienthal, N Herold - International journal of molecular sciences, 2020 - mdpi.com
Osteosarcoma is the most common primary malignant bone tumour in children and
adolescents. Due to micrometastatic spread, radical surgery alone rarely results in cure …
adolescents. Due to micrometastatic spread, radical surgery alone rarely results in cure …
Cancer stem cells in osteosarcoma
HK Brown, M Tellez-Gabriel, D Heymann - Cancer letters, 2017 - Elsevier
Osteosarcoma is the most common primary bone tumour in children and adolescents and
advanced osteosarcoma patients with evidence of metastasis share a poor prognosis …
advanced osteosarcoma patients with evidence of metastasis share a poor prognosis …
Osteosarcoma: cells‐of‐origin, cancer stem cells, and targeted therapies
Osteosarcoma (OS) is the most common type of primary solid tumor that develops in bone.
Although standard chemotherapy has significantly improved long‐term survival over the past …
Although standard chemotherapy has significantly improved long‐term survival over the past …
Mechanisms of resistance to conventional therapies for osteosarcoma
L Marchandet, M Lallier, C Charrier, M Baud'huin… - Cancers, 2021 - mdpi.com
Simple Summary Osteosarcoma (OS), the most common primary bone tumor, mainly affects
children and adolescents. Unfortunately, in some cases, the absence of response to …
children and adolescents. Unfortunately, in some cases, the absence of response to …
Cells of origin in osteosarcoma: mesenchymal stem cells or osteoblast committed cells?
Osteosarcoma is a disease with many complex genetic abnormalities but few well defined
genetic drivers of tumor initiation and evolution. The disease is diagnosed and defined …
genetic drivers of tumor initiation and evolution. The disease is diagnosed and defined …
Molecular mechanisms of chemoresistance in osteosarcoma
H He, J Ni, JUN Huang - Oncology letters, 2014 - spandidos-publications.com
Due to the emergence of adjuvant and neoadjuvant chemotherapy, the survival rate has
been greatly improved in osteosarcoma (OS) patients with localized disease. However, this …
been greatly improved in osteosarcoma (OS) patients with localized disease. However, this …
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt
R Würth, A Pattarozzi, M Gatti, A Bajetto, A Corsaro… - Cell Cycle, 2013 - Taylor & Francis
Cancer stem cell theory postulates that a small population of tumor-initiating cells is
responsible for the development, progression and recurrence of several malignancies …
responsible for the development, progression and recurrence of several malignancies …
[HTML][HTML] Advances in osteosarcoma stem cell research and opportunities for novel therapeutic targets
GN Yan, YF Lv, QN Guo - Cancer letters, 2016 - Elsevier
Osteosarcoma is the most common type of bone cancer, especially in children and young
adults. The primary treatment for osteosarcoma is a combination of surgery and …
adults. The primary treatment for osteosarcoma is a combination of surgery and …
Energy Metabolism Characterization of a Novel Cancer Stem Cell‐L ike Line 3 AB‐OS
R Palorini, G Votta, C Balestrieri… - Journal of cellular …, 2014 - Wiley Online Library
Cancer stem cells (CSC) have a central role in driving tumor growth. Since metabolism is
becoming an important diagnostic and therapeutic target, characterization of CSC line …
becoming an important diagnostic and therapeutic target, characterization of CSC line …
Novel molecular insights and new therapeutic strategies in osteosarcoma
Osteosarcoma (OS) is one of the most prevalent malignant cancers with lower survival and
poor overall prognosis mainly in children and adolescents. Identifying the molecular …
poor overall prognosis mainly in children and adolescents. Identifying the molecular …